Finance

Lists
GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
၂,၅၁၉.၀၀ ₹
+၀.၉၆%
(+၂၄.၀၀) 1D
ဇူ ၂၄, GMT+၅:၃၀ ၁၅:၃၀:၀၀  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for GLAXO...
Open
၂,၄၉၀.၂၀ ₹
High
၂,၅၂၅.၈၀ ₹
Low
၂,၄၅၅.၀၀ ₹
Mkt. cap
ဋေ ၄.၂၆ သ
Avg. vol.
၁.၁၆ သိန်း
Volume
၆.၃၈ သောင်း
Dividend
၂.၂၆%
Quarterly dividend
၁၄.၂၅ ₹
Ex-dividend date
၂၀၂၆ မေ ၂၉
P/E ratio
၄၁.၁၉
52-wk high
၃,၂၂၀.၀၀ ₹
52-wk low
၂,၀၈၈.၁၀ ₹
EPS
၆၁.၁၅ ₹
Shares outstanding
၁၆.၉၄ ကုဋေ
No. of employees
၃ ထောင်
Open
၂,၄၉၀.၂၀ ₹
High
၂,၅၂၅.၈၀ ₹
Low
၂,၄၅၅.၀၀ ₹
Mkt. cap
ဋေ ၄.၂၆ သ
Avg. vol.
၁.၁၆ သိန်း
Volume
၆.၃၈ သောင်း
Dividend
၂.၂၆%
Quarterly dividend
၁၄.၂၅ ₹
Ex-dividend date
၂၀၂၆ မေ ၂၉
P/E ratio
၄၁.၁၉
52-wk high
၃,၂၂၀.၀၀ ₹
52-wk low
၂,၀၈၈.၁၀ ₹
EPS
၆၁.၁၅ ₹
Shares outstanding
၁၆.၉၄ ကုဋေ
No. of employees
၃ ထောင်
News stories
From sources across the web
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၁ နာရီ
Fluence Energy, Inc. (NASDAQ:FLNC) Given Average Recommendation of "Hold" by Brokerages
Investor's Business Daily
Investor's Business Daily
·
ပြီးခဲ့သည့် ၄ နာရီ
Dow Jones Futures: Market Triggers Sell Signal; Apple Earnings, Iran News, Fed Meeting In Focus
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees၃.၁ ထောင်
Founded၁၉၂၄ နို ၁၃
Headquarters-
Sector-
Next call ၈ ရက်အတွင်း
ဩ ၃ တနင်္လာ, ၈:၄၅
Fiscal period
Q1 2027
EPS / Est. (INR)
- / ၁၃.၉၀ ₹
Revenue / Est. (INR)
- / ၉၁၁.၁၅ ဋေ
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
၈၀၅.၁၇ ဋေ
၉၇၉.၉၄ ဋေ
ဋေ ၁.၀၄ ထ
၉၉၅.၃၀ ဋေ
Cost of goods sold
၂၈၇.၇၁ ဋေ
၃၅၅.၅၃ ဋေ
၃၆၃.၈၂ ဋေ
၃၆၈.၅၆ ဋေ
Cost of revenue
၂၈၇.၇၁ ဋေ
၃၅၅.၅၃ ဋေ
၃၆၃.၈၂ ဋေ
၃၆၈.၅၆ ဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁၅၂.၅၇ ဋေ
၁၃၈.၀၅ ဋေ
၁၅၁.၈၈ ဋေ
၂၉၄.၆၈ ဋေ
Operating expense
၂၈၁.၇၈ ဋေ
၃၀၆.၁၁ ဋေ
၃၂၆.၄၂ ဋေ
၂၈၄.၁၇ ဋေ
Total operating expenses
၅၆၉.၄၉ ဋေ
၆၆၁.၆၄ ဋေ
၆၉၀.၂၄ ဋေ
၆၅၂.၇၃ ဋေ
Operating income
၂၃၅.၆၈ ဋေ
၃၁၈.၃၀ ဋေ
၃၅၁.၀၂ ဋေ
၃၄၂.၅၇ ဋေ
Other non operating income
၄၃.၇၂ ကုဋေ
၃၃.၅၇ ကုဋေ
၃၂.၁၂ ကုဋေ
-၁၀၉.၄၁ ဋေ
EBT including unusual items
၂၇၈.၉၈ ဋေ
၃၅၄.၀၀ ဋေ
၃၉၉.၉၃ ဋေ
၃၇၃.၁၀ ဋေ
EBT excluding unusual items
၂၇၈.၉၈ ဋေ
၃၅၁.၃၆ ဋေ
၃၈၁.၉၅ ဋေ
၂၉၃.၅၁ ဋေ
Income tax expense
၇၃.၉၇ ကုဋေ
၉၆.၅၁ ကုဋေ
၁၀၄.၃၁ ဋေ
၉၅.၂၄ ကုဋေ
Effective tax rate
၂၆.၅၁%
၂၇.၂၆%
၂၆.၀၈%
၂၅.၅၃%
Other operating expenses
၁၁၃.၆၉ ဋေ
၁၅၀.၆၃ ဋေ
၁၅၄.၂၂ ဋေ
-၂၃.၆၈ ကုဋေ
Net income
၂၀၅.၀၁ ဋေ
၂၅၇.၄၉ ဋေ
၂၉၅.၆၂ ဋေ
၂၇၇.၈၆ ဋေ
Net profit margin
၂၅.၄၆%
၂၆.၂၈%
၂၈.၃၉%
၂၇.၉၂%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
၆၅.၇၃ ကုဋေ
Interest expense
-၄.၂၀ သန်း
-၅.၁၀ သန်း
-၁.၁၉ ကုဋေ
-၆.၁၂ သန်း
Net interest expenses
-၄.၂၀ သန်း
-၅.၁၀ သန်း
-၁.၁၉ ကုဋေ
၆၅.၁၂ ကုဋေ
Depreciation and amortization charges
၁၅.၅၂ ကုဋေ
၁၇.၄၃ ကုဋေ
၂၀.၃၂ ကုဋေ
၁၃.၁၇ ကုဋေ
EBITDA
၂၄၅.၂၇ ဋေ
၃၃၄.၇၈ ဋေ
၃၆၀.၆၁ ဋေ
၃၅၂.၁၉ ဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more